Patients with MACE exhibited significant differences in ALC, ALB, preoperative PNI, age, BMI, CRP, TG, presence of comorbidities (hypertension, hyperlipidemia, pulmonary infections), history of prior PCI, smoking status, LVEF, Cr, and intervention programs, in comparison to those without MACE. This evidence concerns the gene ALB and hyperlipidemia.